Stevanato Group S.p.A. (STVN)
| Previous close | 20.91 |
| Open | 21.00 |
| Bid | 20.04 x 900 |
| Ask | 21.13 x 900 |
| Day's range | 20.21 - 21.14 |
| 52-week range | 20.01 - 36.30 |
| Volume | |
| Avg. volume | 547,328 |
| Market cap | 5.649B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | 35.10 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.06 (0.23%) |
| Ex-dividend date | 07 Jun 2023 |
| 1y target est | N/A |
- Business Wire
Stevanato Group Reports Financial Results for the First Quarter of 2024
PIOMBINO DESE, Italy, May 09, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2024.
- Business Wire
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
PIOMBINO DESE, Italy, May 01, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Bank of America Securities Healthcare Conference taking place from Tuesday, May 14, 2024 to Thursday, May 16, 2024.
- Business Wire
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
PIOMBINO DESE, Italy, April 25, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2024 on Thursday, May 9, 2024, at 6:30 a.m. (ET).
